Thomas Flaten
Stock Analyst at Lake Street
(0.92)
# 3,478
Out of 4,748 analysts
33
Total ratings
26.47%
Success rate
-13.27%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPTN OptiNose | Maintains: Buy | $45 → $17 | $6.00 | +183.33% | 4 | Jan 16, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $5.01 | +79.64% | 2 | Jan 8, 2025 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $4 → $7 | $2.84 | +146.48% | 4 | Dec 16, 2024 | |
| CSTL Castle Biosciences | Maintains: Buy | $34 → $40 | $27.49 | +45.51% | 5 | Nov 5, 2024 | |
| DERM Journey Medical | Initiates: Buy | $9 | $3.94 | +128.43% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.83 | +261.49% | 3 | Mar 12, 2024 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $3 → $8 | $3.10 | +158.06% | 1 | Mar 7, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $3.22 | +241.61% | 3 | Mar 5, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $28.30 | -11.66% | 2 | Aug 9, 2023 | |
| EVAX Evaxion Biotech | Maintains: Buy | $1,800 → $700 | $3.39 | +20,548.97% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $10 | $2.02 | +395.05% | 4 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $6.93 | +20,679.22% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $5.89 | +35.82% | 1 | Jul 7, 2022 |
OptiNose
Jan 16, 2025
Maintains: Buy
Price Target: $45 → $17
Current: $6.00
Upside: +183.33%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $5.01
Upside: +79.64%
Checkpoint Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $4 → $7
Current: $2.84
Upside: +146.48%
Castle Biosciences
Nov 5, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $27.49
Upside: +45.51%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $3.94
Upside: +128.43%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.83
Upside: +261.49%
Aquestive Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $3 → $8
Current: $3.10
Upside: +158.06%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $3.22
Upside: +241.61%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $28.30
Upside: -11.66%
Evaxion Biotech
Mar 31, 2023
Maintains: Buy
Price Target: $1,800 → $700
Current: $3.39
Upside: +20,548.97%
Dec 1, 2022
Downgrades: Hold
Price Target: $60 → $10
Current: $2.02
Upside: +395.05%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $6.93
Upside: +20,679.22%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $5.89
Upside: +35.82%